GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Emtricitabine (Emtriva)

Local RX List renal extractBase record retrieved 2026-09-05See the evidence for this drug3 sources available - open source summaries, references and comparisons

Emtriva

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (3)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

1 additional source qualifications - review before use
EMTRIVA versus NIH: explicit renal schedule deviation

The standalone capsule/solution label reduces dosing at selected bands where NIH uses no adjustment. NIH footnote b explains its incorporation of some fixed-dose-product guidance.

Before applying: Choose and document one applicable institutional/specialist approach. Do not average schedules or silently relabel the NIH approach as the standalone product label.

Also check: EMTRIVA versus NIH: explicit renal schedule deviation

Rxlist source

GlobalRPh RX List - EMTRIVA

Product / population
Adult standalone EMTRIVA: capsules and 10 mg/mL oral solution have distinct renal schedules. Not automatic guidance for FTC-containing combination tablets.
Renal measure
Estimated creatinine clearance (CrCl), mL/min. The selected subsection does not independently establish an estimating equation.

RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.

Renal dosing, restrictions and evidence limits

Adult renal table (CrCl in mL/min):

CrClCapsuleOral solution 10 mg/mL
>=50200 mg every 24 hours240 mg (24 mL) daily
30 to 49200 mg every 48 hours120 mg (12 mL) daily
15 to 29200 mg every 72 hours80 mg (8 mL) daily
<15 or hemodialysis200 mg every 96 hours60 mg (6 mL) daily

On hemodialysis days, administer after dialysis. Efficacy of these reduced-renal-function schedules has not been clinically evaluated; pediatric renal data are insufficient. NIH guidance differs at selected bands and is stored separately.

Source revision: Source revision date not established in selected retrieval. | Retrieved: 2026-09-08. Retrieval date is not the revision date.

Source: https://globalrph.com/rx-list/emtriva-drug/

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

Read local renal resultOpen original reference
GlobalRPh RX List

GlobalRPh RX List - EMTRIVA

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Adult standalone EMTRIVA: capsules and 10 mg/mL oral solution have distinct renal schedules. Not automatic guidance for FTC-containing combination tablets.

Renal method: Estimated creatinine clearance (CrCl), mL/min. The selected subsection does not independently establish an estimating equation.
Retrieved: 2026-09-08

Read local renal resultOpen original reference
Professional guidance

Emtricitabine - NIH adult HIV guidance

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

NIH adult/adolescent ART table; professional guidance differs from standalone EMTRIVA labeling.

Renal method: Cockcroft-Gault creatinine clearance (CrCl), mL/min; not BSA-indexed laboratory eGFR.
Retrieved: 2026-09-08

Read local renal resultOpen original reference

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Product / population check

Confirm the exact formulation before using a renal source

These links compare product identities, not interchangeable doses. A selected summary is not a complete prescribing monograph.

Source-specific review points

EMTRIVA versus NIH: explicit renal schedule deviation

Read the attributed comparison notes and source cards below. No conflict has been silently adjudicated.

Source-quality holds
Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources
Jump to renal guidanceRead 1 difference / caution notesClinician guide

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

guideline difference

EMTRIVA versus NIH: explicit renal schedule deviation

The standalone capsule/solution label reduces dosing at selected bands where NIH uses no adjustment. NIH footnote b explains its incorporation of some fixed-dose-product guidance.

How to use this: Choose and document one applicable institutional/specialist approach. Do not average schedules or silently relabel the NIH approach as the standalone product label.

GlobalRPh RX List - EMTRIVAEmtricitabine - NIH adult HIV guidanceEmtricitabine/tenofovir disoproxil fumarate (Truvada)Emtricitabine / tenofovir alafenamide - DESCOVYEmtricitabine / rilpivirine / TAF - ODEFSEYEmtricitabine / rilpivirine / TDF - COMPLERA

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.
Rxlist source

GlobalRPh RX List - EMTRIVA

Adult standalone EMTRIVA: capsules and 10 mg/mL oral solution have distinct renal schedules. Not automatic guidance for FTC-containing combination tablets.

Method: Estimated creatinine clearance (CrCl), mL/min. The selected subsection does not independently establish an estimating equation.

Renal dosing, restrictions and evidence limitsRead this complete source summary

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Original content / product scopeGlobalRPh RX List - EMTRIVAEmtricitabine - NIH adult HIV guidance
Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/emtricitabine/

Usual Dosing (Adults)

May take without regard to food. Age >=18: one 200 mg capsule orally daily, or oral solution 240 mg (24 mL) daily.

Age 0 to 3 months: solution 3 mg/kg daily. Age 3 months through 17 years: solution 6 mg/kg daily up to 240 mg (24 mL). Children >33 kg who can swallow intact capsules: one 200 mg capsule daily.

GRPH-emtricitabine-01 · Source section: Usual Dosing (Adults)Renal section finder

Renal Dosing

Adult adjustments by formulation:

CrClCapsuleOral solution 10 mg/mL
>=50 mL/min200 mg every 24 hours240 mg (24 mL) every 24 hours
30 to 49200 mg every 48 hours120 mg (12 mL) every 24 hours
15 to 29200 mg every 72 hours80 mg (8 mL) every 24 hours
<15 or hemodialysis200 mg every 96 hours60 mg (6 mL) every 24 hours

Insufficient pediatric renal data to recommend a specific dose; the source advises considering a dose reduction and/or interval extension similar to adult adjustment.

GRPH-emtricitabine-02 · Source section: Renal DosingRenal section finder

Hemodialysis

Use the formulation-specific table. If dosing on a dialysis day, administer after dialysis.

GRPH-emtricitabine-03 · Source section: HemodialysisRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - EMTRIVA

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Adult standalone EMTRIVA: capsules and 10 mg/mL oral solution have distinct renal schedules. Not automatic guidance for FTC-containing combination tablets.

Renal method: Estimated creatinine clearance (CrCl), mL/min. The selected subsection does not independently establish an estimating equation.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-08

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

Adult renal table (CrCl in mL/min):

CrClCapsuleOral solution 10 mg/mL
>=50200 mg every 24 hours240 mg (24 mL) daily
30 to 49200 mg every 48 hours120 mg (12 mL) daily
15 to 29200 mg every 72 hours80 mg (8 mL) daily
<15 or hemodialysis200 mg every 96 hours60 mg (6 mL) daily

On hemodialysis days, administer after dialysis. Efficacy of these reduced-renal-function schedules has not been clinically evaluated; pediatric renal data are insufficient. NIH guidance differs at selected bands and is stored separately.

RDM45-rxlist-emtricitabine-c889611c30-C1 · Source locator: Dosage and Administration: Renal Impairment, adult capsule/solution table and footnotes, lines 49-72.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/emtriva-drug/
Retrieved
2026-09-08
Renal-function method
Estimated creatinine clearance (CrCl), mL/min. The selected subsection does not independently establish an estimating equation.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
ee1695e85ffd0d5489f679765885f069680467fa517051493e1584a273100b29
Separate professional-source layer

University and professional protocols

Professional

Emtricitabine - NIH adult HIV guidance

Open original reference

Open / share this exact local source

NIH / HHS Adult and Adolescent Antiretroviral Guidelines Panel · NIH adult/adolescent ART table; professional guidance differs from standalone EMTRIVA labeling.

Renal method: Cockcroft-Gault creatinine clearance (CrCl), mL/min; not BSA-indexed laboratory eGFR.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-08

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

NIH lists the usual adult FTC dose as a 200 mg capsule daily or 240 mg (24 mL) oral solution daily. It uses no adjustment at CrCl 30 to 49 mL/min and in hemodialysis, with administration after dialysis. Footnote b explicitly incorporates dosing from certain FTC-containing fixed-dose products despite the standalone EMTRIVA label's reductions. Keep this expert-guidance approach separate from the label schedule; it is not a silent label correction or universal pediatric rule.

RDM45-professional-emtricitabine-9335c87ac0-C1 · Source locator: FTC row, lines 20-27; footnote b, line 259.

Source-specific limits

Page revision date not established from selected rendering. Retrieved 2026-09-08. This is treatment guidance, not a PrEP protocol.

Source identity and provenance
Source family
professional_guidance
Source
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables-renal-hepatic-insufficiency-full
Retrieved
2026-09-08
Renal-function method
Cockcroft-Gault creatinine clearance (CrCl), mL/min; not BSA-indexed laboratory eGFR.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
830d886ff53071285392cfec39ea36c9f32ad15e069f8287c08aa3dd2f8c115d

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 1 RX List, 1 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/emtricitabine/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
bd78d6c090672e079f1ee7ce55f0f4cbc4a994e3746dc27d098df9b91a031e9a
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report